Results 271 to 280 of about 105,845 (307)
Some of the next articles are maybe not open access.
Design of hepatitis A vaccines
British Medical Bulletin, 1990Hepatitis A is a major public health problem in many rapidly developing countries and it is still an important disease in many developed countries. Isolation of the virus in cell culture and access to reliable animal models has led to the development of several candidate vaccines.
openaire +2 more sources
Journal of Hepatology, 2003
Yeast-derived hepatitis B vaccines, containing the small HBV envelope protein SHBAg, are immunogenic, safe and cost-effective in prevention of hepatitis B virus infection in neonates, children and adults. Newly developed pre-S/S hepatitis B vaccines may play a role in inducing fast and augmented seroconversion rates in special risk groups.
openaire +2 more sources
Yeast-derived hepatitis B vaccines, containing the small HBV envelope protein SHBAg, are immunogenic, safe and cost-effective in prevention of hepatitis B virus infection in neonates, children and adults. Newly developed pre-S/S hepatitis B vaccines may play a role in inducing fast and augmented seroconversion rates in special risk groups.
openaire +2 more sources
Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality
Journal of Hepatology, 2021Alba Rocco +2 more
exaly
Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial
Lancet, The, 1999Maria Elena Tosti +2 more
exaly